Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 229 (RNA5SP229)

Target
RNA5SP229
Molecular classification
Pseudogene, rRNA pseudogene, Non-coding RNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 229 (RNA5SP229) is a processed pseudogene that resembles the 5S ribosomal RNA gene but does not encode a functional RNA product. Pseudogenes in general arise from duplication or retrotransposition events and accumulate disabling mutations, so they are typically nonfunctional at the protein or RNA level. Some pseudogenes have been implicated in gene regulation, often as non-coding RNAs, but there is no established function or therapeutic relevance for RNA5SP229 specifically. The term "pseudogene" differentiates it from active 5S rRNA genes, which are components of the ribosome and essential for protein synthesis. RNA5SP229 is annotated as a pseudogene in standard gene databases and carries no known function or relevance as a drug target. Pseudogenes broadly can be transcribed and may play indirect regulatory roles in disease, but these functions are not generalized to all pseudogenes, nor is there specific evidence for disease involvement for RNA5SP229. RNA5SP229 is not a receptor, enzyme, transporter, or recognized therapeutic target. This is a non-protein-coding, non-functional pseudogene, with no evidence supporting its use or consideration as a therapeutic target. It is sometimes considered in large-scale molecular studies (such as cancer transcriptomics) as part of overall pseudogene expression, but individually, RNA5SP229 does not have known clinical or pharmacological significance.

Other names
RN5S229RNA, 5S ribosomal 229RNA5SP229
02

Mechanism of action

None

03

Biological functions

No direct biological functionsome pseudogenes may play regulatory roles such as acting as long non-coding RNAs
04

Disease associations

Not established for this particular pseudogene; studies suggest some pseudogenes may serve as biomarkers or be involved in cancer biology broadly, but direct evidence for RNA5SP229 is lacking
05

Biomarkers

In general, pseudogene expression has been explored as a prognostic biomarker in some cancers, but RNA5SP229 specifically is not established as a biomarker

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 229 (RNA5SP229).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 229 (RNA5SP229).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call